Sen. Kennedy’s Foreign Inspection Bill Gives FDA More Flexibility Than House
This article was originally published in The Tan Sheet
Executive Summary
House and Senate Democrats are taking similar approaches to invigorate FDA's ability to oversee foreign manufacturing facilities. Some fundamental differences and Republican concerns, however, suggest the issue will likely not be resolved until at least the next Congress